EUVIMEDEUVIMED entdecken
Open Access

LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation

Matthew B Murphy iD, Zhenjiang Yang, Tuerdi Subati, Eric Farber-Eger, Kyungsoo Kim, Daniel J Blackwell, Matthew R Fleming, Joshua M Stark, Joseph C Van Amburg, Kaylen K Woodall, Justin P Van Beusecum, Vineet Agrawal und 10 weitere

Cardiovascular Research · 2024

DOI: 10.1093/cvr/cvae036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Matthew B Murphy und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, 2220 Pierce Avenue, 559 PRB, Nashville, TN 37232…. Hauptthemen laut MEDLINE: Action Potentials, Adaptor Proteins, Signal Transducing, Atrial Fibrillation, Disease Models, Animal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The lymphocyte adaptor protein (LNK) is a negative regulator of cytokine and growth factor signalling. The rs3184504 variant in SH2B3 reduces LNK function and is linked to cardiovascular, inflammatory, and haematologic disorders, including stroke. In mice, deletion of Lnk causes inflammation and oxidative stress. We hypothesized that Lnk−/− mice are susceptible to atrial fibrillation (AF) and that rs3184504 is associated with AF and AF-related stroke in humans. During inflammation, reactive lipid dicarbonyls are the major components of oxidative injury, and we further hypothesized that these mediators are critical drivers of the AF substrate in Lnk−/− mice. Methods and results Lnk−/− or wild-type (WT) mice were treated with vehicle or 2-hydroxybenzylamine (2-HOBA), a dicarbonyl scavenger, for 3 months. Compared with WT, Lnk−/− mice displayed increased AF duration that was prevented by 2-HOBA. In the Lnk−/− atria, action potentials were prolonged with reduced transient outward K+ current, increased late Na+ current, and reduced peak Na+ current, pro-arrhythmic effects that were inhibited by 2-HOBA. Mitochondrial dysfunction, especially for Complex I, was evident in Lnk−/− atria, while scavenging lipid dicarbonyls prevented this abnormality. Tumour necrosis factor-α (TNF-α) and interleukin-1 beta (IL-1β) were elevated in Lnk−/− plasma and atrial tissue, respectively, both of which caused electrical and bioenergetic remodelling in vitro. Inhibition of soluble TNF-α prevented electrical remodelling and AF susceptibility, while IL-1β inhibition improved mitochondrial respiration but had no effect on AF susceptibility. In a large database of genotyped patients, rs3184504 was associated with AF, as well as AF-related stroke.

Conclusion

These findings identify a novel role for LNK in the pathophysiology of AF in both experimental mice and humans. Moreover, reactive lipid dicarbonyls are critical to the inflammatory AF substrate in Lnk−/− mice and mediate the pro-arrhythmic effects of pro-inflammatory cytokines, primarily through electrical remodelling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Action PotentialsAdaptor Proteins, Signal TransducingAtrial FibrillationDisease Models, AnimalInterleukin-1betaMice, Inbred C57BLMice, KnockoutMyocytes, CardiacAnimalsFemaleHumansMaleBenzylaminesGenetic Predisposition to DiseaseHeart RateInflammation MediatorsIntracellular Signaling Peptides and ProteinsMitochondria, HeartOxidative StressPhenotypeSignal TransductionTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

Atrial fibrillationInflammationIsolevuglandinsOxidative stressPro-inflammatory cytokines

Substanzen

Adaptor Proteins, Signal TransducingBenzylaminesIL1B protein, mouseInflammation MediatorsInterleukin-1betaIntracellular Signaling Peptides and ProteinsTnf protein, mouseTumor Necrosis Factor-alphaSH2B3 protein, human

Autor:innen und Institutionen

  • Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, 2220 Pierce Avenue, 559 PRB, Nashville, TN 37232, USA.
  • Department of Pharmacology, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Nashville, TN 37232, USA.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, 1161 21 Avenue South, Nashville, TN 37232, USA.
  • Department of Biomedical Informatics, Vanderbilt University School of Medicine, 2525 West End Avenue, Nashville, TN 37203, USA.

ORCID-Profile: Matthew B Murphy, Charles D Smart, Annet Kirabo, Katherine T Murray

Förderung

  • NCATS NIH HHS
  • NIDDK NIH HHS
  • NIH HHS
  • NHLBI NIH HHS
  • Intramural NIH HHS
  • American Heart Association
  • Vanderbilt Cell Imaging Shared Resource
  • NCI NIH HHS

Zitieren

APA

Murphy, M. B., Yang, Z., Subati, T., Farber-Eger, E., Kim, K., Blackwell, D. J., Fleming, M. R., Stark, J. M., Van Amburg, J. C., Woodall, K. K., Van Beusecum, J. P., Agrawal, V., Smart, C. D., Pitzer, A., Atkinson, J. B., Fogo, A. B., Bastarache, J. A., Kirabo, A., Wells, Q. S., …, & Murray, K. T. (2024). LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae036

Vancouver

Murphy MB, Yang Z, Subati T, Farber-Eger E, Kim K, Blackwell DJ, et al. LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae036

BibTeX
@article{Murphy2024,
  author = {Murphy, Matthew B and Yang, Zhenjiang and Subati, Tuerdi and Farber-Eger, Eric and Kim, Kyungsoo and Blackwell, Daniel J and Fleming, Matthew R and Stark, Joshua M and Van Amburg, Joseph C and Woodall, Kaylen K and Van Beusecum, Justin P and Agrawal, Vineet and Smart, Charles D and Pitzer, Ashley and Atkinson, James B and Fogo, Agnes B and Bastarache, Julie A and Kirabo, Annet and Wells, Quinn S and Madhur, Meena S and Barnett, Joey V and Murray, Katherine T},
  title = {LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation},
  journal = {Cardiovascular Research},
  year = {2024},
  doi = {10.1093/cvr/cvae036}
}
Kostenlos starten →